Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. osteosarcoma
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

Osteosarcoma Articles & Analysis

4 news found

SERB receives EU approval for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

SERB receives EU approval for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

About High Dose Methotrexate Toxicity High Dose Methotrexate (HDMTX) chemotherapy is used to treat or prevent the recurrence of certain types of cancer in adults and children, such as leukaemia, lymphoma, and osteosarcoma. Despite standard supportive measures, HDTMX may induce renal dysfunction in some patients, delaying MTX elimination. ...

ByBTG International Inc.


First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021

First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021

” High dose MTX chemotherapy is used to treat or prevent the recurrence of certain types of cancer in both adults and children, such as leukaemia, lymphoma, and osteosarcoma. In Spain, 1,475 patients are treated annually with HDMTX. In the hospitals where Voraxaze® is available, 63% of patients would be medically eligible to receive it. ...

ByBTG International Inc.


SERB receives positive CHMP opinion for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

SERB receives positive CHMP opinion for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

About High Dose Methotrexate Toxicity High Dose Methotrexate (HDMTX) chemotherapy is used to treat or prevent the recurrence of certain types of cancer in adults and children, such as leukaemia, lymphoma, and osteosarcoma. Despite standard supportive measures, HDTMX may induce renal dysfunction in some patients, delaying MTX elimination. ...

ByBTG International Inc.


TVAX Biomedical Names Wayne Carter as President and CEO

TVAX Biomedical Names Wayne Carter as President and CEO

The TVAX vaccine-enhanced adoptive T cell therapy was licensed to Elias Animal Health to develop the technology as cancer immunotherapy for companion animals and, in particular, dogs with osteosarcoma. Dr. Carter comes with extensive clinical research expertise in both human and animal medicine. ...

ByTVAX Biomedical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT